Cuadrado et al., 2019 - Google Patents
Specific contributions of cohesin-SA1 and cohesin-SA2 to TADs and polycomb domains in embryonic stem cellsCuadrado et al., 2019
View HTML- Document ID
- 7292865337623067736
- Author
- Cuadrado A
- Gimenez-Llorente D
- Kojic A
- Rodríguez-Corsino M
- Cuartero Y
- Martín-Serrano G
- Gomez-Lopez G
- Marti-Renom M
- Losada A
- Publication year
- Publication venue
- Cell reports
External Links
Snippet
Cohesin exists in two variants carrying either STAG/SA1 or SA2. Here we have addressed their specific contributions to the unique spatial organization of the mouse embryonic stem cell genome, which ensures super-enhancer-dependent transcription of pluripotency factors …
- 210000001671 Embryonic Stem Cells 0 title abstract description 9
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6802—General aspects
- C12Q1/6809—Sequence identification involving differential detection
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/12—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for modelling or simulation in systems biology, e.g. probabilistic or dynamic models, gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
- G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F9/00—Arrangements for programme control, e.g. control unit
- G06F9/06—Arrangements for programme control, e.g. control unit using stored programme, i.e. using internal store of processing equipment to receive and retain programme
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cuadrado et al. | Specific contributions of cohesin-SA1 and cohesin-SA2 to TADs and polycomb domains in embryonic stem cells | |
| Ren et al. | CTCF-mediated enhancer-promoter interaction is a critical regulator of cell-to-cell variation of gene expression | |
| Xiao et al. | Pervasive chromatin-RNA binding protein interactions enable RNA-based regulation of transcription | |
| Saldaña-Meyer et al. | RNA interactions are essential for CTCF-mediated genome organization | |
| Guo et al. | Dysregulation of EMT drives the progression to clinically aggressive sarcomatoid bladder cancer | |
| Sun et al. | Promoter-enhancer communication occurs primarily within insulated neighborhoods | |
| Rhodes et al. | Cohesin disrupts polycomb-dependent chromosome interactions in embryonic stem cells | |
| Narita et al. | Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes | |
| Reverón-Gómez et al. | Accurate recycling of parental histones reproduces the histone modification landscape during DNA replication | |
| Clouaire et al. | Comprehensive mapping of histone modifications at DNA double-strand breaks deciphers repair pathway chromatin signatures | |
| Jeselsohn et al. | Allele-specific chromatin recruitment and therapeutic vulnerabilities of ESR1 activating mutations | |
| Ullrich et al. | Dynamic changes in intron retention are tightly associated with regulation of splicing factors and proliferative activity during B-cell development | |
| Knaupp et al. | Transient and permanent reconfiguration of chromatin and transcription factor occupancy drive reprogramming | |
| Ramírez et al. | High-resolution TADs reveal DNA sequences underlying genome organization in flies | |
| Li et al. | Foxa2 and H2A. Z mediate nucleosome depletion during embryonic stem cell differentiation | |
| Kundu et al. | Polycomb repressive complex 1 generates discrete compacted domains that change during differentiation | |
| Rosenbluh et al. | Complementary information derived from CRISPR Cas9 mediated gene deletion and suppression | |
| Siersbæk et al. | Dynamic rewiring of promoter-anchored chromatin loops during adipocyte differentiation | |
| G Hendrickson et al. | Widespread RNA binding by chromatin-associated proteins | |
| Chandra et al. | Global reorganization of the nuclear landscape in senescent cells | |
| Iwasaki et al. | Piwi modulates chromatin accessibility by regulating multiple factors including histone H1 to repress transposons | |
| Baltz et al. | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts | |
| Liang et al. | Chromatin immunoprecipitation indirect peaks highlight long-range interactions of insulator proteins and Pol II pausing | |
| Cao et al. | Novel approach reveals genomic landscapes of single-strand DNA breaks with nucleotide resolution in human cells | |
| Ashouri et al. | Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events |